Cargando…

Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs’ Revolution for Immunotherapy

Despite several therapeutic advances, malignant melanoma still remains a fatal disease for which novel and long-term curative treatments are needed. The successful development of innovative therapies strongly depends on the availability of appropriate pre-clinical models. For this purpose, several m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barutello, Giuseppina, Rolih, Valeria, Arigoni, Maddalena, Tarone, Lidia, Conti, Laura, Quaglino, Elena, Buracco, Paolo, Cavallo, Federica, Riccardo, Federica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877660/ https://www.ncbi.nlm.nih.gov/pubmed/29534457 http://dx.doi.org/10.3390/ijms19030799

Ejemplares similares

CSPG4: a prototype oncoantigen for translational immunotherapy studies
por: Rolih, Valeria, et al.
Publicado: (2017)

Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial
por: Riccardo, Federica, et al.
Publicado: (2022)

Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy
por: Peppino, Giulia, et al.
Publicado: (2022)

Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas
por: Riccardo, Federica, et al.
Publicado: (2020)

Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research
por: Tarone, Lidia, et al.
Publicado: (2022)

Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy
por: Peppino, Giulia, et al.
Publicado: (2021)

Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer
por: Ruiu, Roberto, et al.
Publicado: (2021)

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo
por: Bolli, Elisabetta, et al.
Publicado: (2017)

Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma
por: Riccardo, Federica, et al.
Publicado: (2019)

Antitumor immunization of mothers delays tumor development in cancer-prone offspring
por: Barutello, Giuseppina, et al.
Publicado: (2015)

Angiomotin like-1 is a novel component of the N-cadherin complex affecting endothelial/pericyte interaction in normal and tumor angiogenesis
por: Zheng, Yujuan, et al.
Publicado: (2016)

The Dawn of the standard revolution
por: DE RUJULA, Alvaro
Publicado: (2014)

Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer
por: Rolih, Valeria, et al.
Publicado: (2020)

Improving Osteosarcoma Treatment: Comparative Oncology in Action
por: Tarone, Lidia, et al.
Publicado: (2022)

Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models
por: Barutello, Giuseppina, et al.
Publicado: (2022)

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice
por: Bandini, Silvio, et al.
Publicado: (2013)

A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model
por: Msaki, Aichi, et al.
Publicado: (2016)

A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors
por: Arigoni, Maddalena, et al.
Publicado: (2012)

On the state of crystallography at the dawn of the electron microscopy revolution
por: .Higgins, Matthew K, et al.
Publicado: (2017)

Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns
por: Riccardo, Federica, et al.
Publicado: (2017)

Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis
por: Macagno, Marco, et al.
Publicado: (2022)

Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retrospective study on 155 cases
por: Giacobino, Davide, et al.
Publicado: (2021)

Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice
por: Conti, Laura, et al.
Publicado: (2014)

Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)
por: Camerino, Mariateresa, et al.
Publicado: (2021)

Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota
por: Di Lorenzo, Antonino, et al.
Publicado: (2020)

Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies
por: Magri, Jolanda, et al.
Publicado: (2021)

Internal lecture: The dawn of the Standard Model's revolution | 6 June | Main Auditorium
Publicado: (2014)

Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2(+) mammary cancer
por: Jacca, Sarah, et al.
Publicado: (2015)

Protection of mice against the highly pathogenic VV(IHD-J) by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity
por: Bissa, Massimiliano, et al.
Publicado: (2016)

At the Dawn of a Therapeutic Revolution for Atopic Dermatitis: An Interview with Dr Anne-Claire Fougerousse
por: Fougerousse, Anne-Claire
Publicado: (2021)

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers
por: Riccardo, Federica, et al.
Publicado: (2014)

Radiotherapy combined with immunotherapy: the dawn of cancer treatment
por: Zhang, Zengfu, et al.
Publicado: (2022)

The Revolution of Immunotherapy in Gynecological Cancers: The Lazarus Effect in Endometrial Cancer
por: Ducceschi, Monika, et al.
Publicado: (2023)

Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
por: Wirth, Thomas C., et al.
Publicado: (2017)

MR1-restricted T cells: the new dawn of cancer immunotherapy
por: Wang, Zhiding, et al.
Publicado: (2020)

Novel insights into Notum and glypicans regulation in colorectal cancer
por: De Robertis, Mariangela, et al.
Publicado: (2015)

Cutaneous melanoma and the immunotherapy revolution (Review)
por: Leonardi, Giulia C., et al.
Publicado: (2020)

Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?
por: Ruiu, Roberto, et al.
Publicado: (2022)

mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
por: Deng, Zhuoya, et al.
Publicado: (2022)

The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints
por: Giuffrida, Paolo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a7sh0rpudj0umbdbdk26c20398